Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
14.00p
(1.85%)
- Add to watchlist
- Create an alert
- This stock can be held in a
14.00p
(1.85%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
14.00p
(1.85%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
757.00p
758.20p
979.00p
821.58
758.00p
741.76p
715.00p
-8.35%
5.00p (0.66%) Previous:
5.00p
28,208
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
| 1 week 1W | 0.26% | 1 year 1Y | 19.28% |
|---|---|---|---|
| 1 month 1M | 3.84% | 2 years 2Y | 37.25% |
| 3 months 3M | 3.68% | 3 years 3Y | 47.87% |
| 6 months 6M | 8.23% | 5 years 5Y | 8.6% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
| Benchmark: | NASDAQ Biotechnology TR GBP |
|---|---|
| Annual management charge: | n/a |
| Performance fee: | Yes |
| Ongoing charge: | 1.30% |
| Dividend yield: | n/a |
| Dividend frequency: | None |
| Total assets: | £298m |
| Gross gearing: | 2% |
| Market capitalisation:Market cap.: | £267m |
| Shares in issue: | 34.98 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
| Estimated NAV: | 821.58 |
|---|---|
| Latest actual NAV: | 819.12 |
| Latest actual NAV date: | 24 November 2023 |
| Premium/Discount: | -8.35% |
| 12m average Premium/Discount: | -7.99% |
| NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
| Security | Weight |
|---|---|
| Amgen Inc | 7.13% |
| Biogen Inc | 6.53% |
| Argen X SE EUR0.10 | 5.26% |
| Biomarin Pharmaceutical Inc | 5.21% |
| Syndax Pharmaceuticals Inc | 4.90% |
| Ionis Pharmaceuticals Inc | 4.62% |
| Vera Therapeutics Inc Class A | 4.42% |
| Xtalpi | 3.99% |
| Travere Therapeutics Inc Ordinary Shares | 3.53% |
| United Therapeutics Corp | 3.42% |
| Sector | Weight |
|---|---|
| Healthcare | 98.65% |
| Country | Weight |
|---|---|
| United States | 90.70% |
| China | 4.09% |
| Canada | 3.97% |
| Netherlands | 1.53% |
| Germany | 1.47% |
| Switzerland | 0.73% |
| Denmark | 0.15% |
Key Dates
| Launch date: | 23 June 1997 |
|---|---|
| Financial year end: | March |
| Next AGM: | July 2024 |
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.